Skip to content

Depression: all studies

Page 824 of 1,034: studies 8,231 to 8,240 of 10,336, newest first. Back to the depression overview

Research

The subsystem mechanism of default mode network underlying rumination: A reproducible neuroimaging study

Neuroimage July 22, 2020 Xiao Chen, Ning-Xuan Chen, Yang-Qian Shen et al.

Rumination is a repetitive self-referential thinking style that is often interpreted as an expression of abnormalities of the default mode network (DMN) observed during "resting-state" in major depressive disorder (MDD). Recent evidence has demonstrated that the DMN is not unitary but can be further divided into 3 functionally heterogenous subsystems, although the subsystem mechanistically...

Role of autobiographical memory in the impact of MBCT on dysfunctional attitudes, depressive symptoms and anxiety in bipolar I patients.

Journal of Affective Disorders July 21, 2020 Aurélie Docteur, Christine Mirabel-Sarron, Héline Kaya Lefèvre et al.

BACKGROUND The literature suggests that cognitive reactivity in bipolar patients can increase relapse vulnerability, is enhanced by depressive mood and dysfunctional attitudes, and could be improved with MBCT. Autobiographical memory (AM) could be involved in cognitive reactivity, and improved with MBCT training. This study aims to investigate the effect of MBCT for bipolar patients on...

4 Psychedelics: therapeutic mechanisms

Journal of Neurology, Neurosurgery, and Psychiatry July 20, 2020 Robin Carhart-Harris

Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University. At Imperial, he has designed and/or carried out brain imaging studies involving LSD, psilocybin, MDMA and DMT, plus a clinical trial of psilocybin for treatment-resistant depression, and an ongoing study...

DOI: 10.1136/jnnp-2020-bnpa.4 (opens in new tab) Psilocybin Hallucinogen Psychoanalysis Psychotherapist

ROLE OF BHRAMARI PRANAYAMA IN PREVENTION AND PROMOTION OF MENTAL HEALTH - A REVIEW

International Ayurvedic Medical Journal July 18, 2020 Pranita K Shinde, Kalpana Jadhao, Pradnya Shinde et al.

Background -In today’s era lifestyle of people has become very mechanical. Everyone is running in a rat race for target achievement, which results in stress. This stress further effects on physical as well as mental health of an individual. Mental health is the balanced development of emotional attitudes and personality which live harmoniously with all society or community. Mental disorders are...

Biological mechanism study of meditation and its application in mental disorders

General Psychiatry July 13, 2020 Hui Shen, Meijuan Chen, Donghong Cui 43 citations

In recent years, research on meditation as an important alternative therapy has developed rapidly and been widely applied in clinical medicine. Mechanism studies of meditation have also developed progressively, showing that meditation has great impact on brain structure and function, and epigenetic and telomere regulation. In line with this, the application of meditation has gradually been...

Two newly-emerging substituted phenethylamines MAL and BOD induce differential psychopharmacological effects in rodents

Journal of Psychopharmacology July 10, 2020 Raly James Perez Custodio, Leandro Val Sayson, Chrislean Jun Botanas et al. 15 citations

Background: Recently, the recreational use of substituted phenethylamines has grown rapidly. Among these are 2-(3,5-dimethoxy-4-((2-methylallyl)oxy)phenyl)ethanamine (MAL) and 2-(2,5-dimethoxy-4-methylphenyl)-2-methoxyethan-1-amine (BOD). However, studies characterizing their abuse potential are still lacking. Aim: The purpose of this study was to investigate the abuse potential of MAL and BOD....

DOI: 10.1177/0269881120936458 (opens in new tab) Ventral tegmental area Nucleus accumbens Conditioned place preference Mesolimbic pathway +2

Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca

Journal of Psychopharmacology July 10, 2020 Nicole Leite Galvão‐coelho, Ana Cecília de Menezes Galvão, Raíssa Nóbrega de Almeida et al. 124 citations

Background: Ayahuasca is a traditional Amazon brew and its potential antidepressant properties have recently been explored in scientific settings. We conducted a double-blind placebo-controlled trial of ayahuasca with treatment-resistant depression patients ( n = 28) and healthy controls ( n = 45). Aims: We are evaluating the blood inflammatory biomarkers: C-reactive protein and interleukin 6,...

DOI: 10.1177/0269881120936486 (opens in new tab) Ayahuasca Antidepressant Placebo Depression economics +4

Longitudinal associations of nightmare frequency and nightmare distress with suicidal behavior in adolescents: mediating role of depressive symptoms

Sleep July 2, 2020 Xianchen Liu, Yanyun Yang, Zhenzhen Liu et al. 41 citations

STUDY OBJECTIVES: Nightmares are a significant risk factor of suicidal behavior. This study examined the longitudinal associations of nightmare frequency and distress with suicidal thought (ST), suicide plan (SP), and suicide attempt (SA) and mediating role of depressive symptoms in adolescents. METHODS: A total of 6,923 adolescents who participated in the 1-year follow-up of Shandong...

Synthesis and characterization of high‐purity N,N‐dimethyltryptamine hemifumarate for human clinical trials

Drug Testing and Analysis July 1, 2020 Nicholas V. Cozzi, Paul F. Daley 12 citations

Abstract Since 2006, there has been a resurgent interest in the pharmacology and therapeutics of psychedelic drugs. Psilocybin, the 4‐phosphoryl ester of N,N ‐dimethyltryptamine (DMT), has been studied most often, but DMT itself is also appealing because of its brief but profound psychological effects and its presence as an endogenous substance in mammalian brain. Although there have been a few...

DOI: 10.1002/dta.2889 (opens in new tab) X-ray powder diffraction Alane Aluminum hydride Pharmaceutical synthesis +12

Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine.

Biochemical Pharmacology July 1, 2020 Kenji Hashimoto 232 citations

Ketamine, an anesthetic developed in the early 1960s, is also a popular abused drug among young people at dance parties and raves and among spiritual seekers, because it produces schizophrenia-like symptoms and dissociation (i.e., out-of-body experience). Regarding mood disorders, ketamine exerts robust antidepressant actions in treatment-resistant patients with depression. Ketamine is a...

DOI: 10.1016/j.bcp.2020.113935 (opens in new tab) Full text (opens in new tab) R-ketamine or arketamine S-ketamine or esketamine Brain-gut-microbiota axis Brain-spleen axis +1